A Multicenter Randomized Controlled Study of Interventional Treatment for Operable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer With Potential Recurrence as Minimal Residual Disease(MRD) Positive

计划入组 213 人 · 首次发布于 2024 年 7 月 29 日

Clinical Multicenter Randomized Controlled Study of Simultaneous Cognitive Training With Transcranial Magnetic Stimulation in the Treatment of VaD-MCI Patients

计划入组 164 人 · 首次发布于 2024 年 6 月 24 日

Clinical Multicenter Randomized Controlled Study of Non-invasive Brain Oscillation Modulation in the Treatment of AD-MCI Patients

计划入组 124 人 · 首次发布于 2024 年 6 月 24 日

PAD4 inhibitors(Capital Medical University)

Ad-TD-nsIL12(Capital Medical University)

Adoptive mononuclear cells therapy(Capital Medical University)

Fuxing Hospital,Capital Medical University

China

Xuanwu Hospital Capital Medical University

China

Beijing Ditan Hospital Capital Medical University

China

Risen Pharma Initiates Phase 2 Trial of RP902 for Alzheimer's Disease in China

OncoC4 Initiates First-in-Class Anti-SIGLEC 10 Antibody Trial for Alzheimer's Disease Treatment

Newcastle University Spin-Out FibroFind Acquired by Vespa Capital to Accelerate Fibrosis Drug Development